AzTrials
AzTrials

Suicidal IdeationNCT06229223

Improving Screening and Follow Up for Suicidal Ideation and Behaviors Among Latinx Youth in Primary Care

A study testing PALOMA in people with Suicidal Ideation, run by Johns Hopkins University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of this proposal is to develop and pilot a systems-level strategy in pediatric primary care to enhance identification and management of suicidal ideation and behavior in Latinx youth, particularly those in immigrant families with parents who have limited English proficiency (LEP). Read more about this study

Who is it for?
Ages 10 to 100 yearsHealthy volunteers can take part
Conditions the study is for
Suicidal Ideation
What is being tested?
PALOMA
Could I receive a placebo?
No, everyone receives an active treatment
How many people
76 participants
Where
1 siteUnited States
Study dates
26 Mar 2024to 6 Jan 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 100 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Youth has history of suicidal ideation/behavior or non-suicidal self-harm and
  • Youth identifies as Latino/Latinx/Hispanic/Latin American and
  • Guardian(s) speaks Spanish

Who cannot join

  • None

Trial locations and contacts

1 site in 1 country.

United States1 site
  • BMS at Yard 56

    Baltimore, Maryland, 21224

Other trials in United States

About this study

The objective of this proposal is to develop and pilot a systems-level strategy in pediatric primary care to enhance identification and management of suicidal ideation and behavior in Latinx youth, particularly those in immigrant families with parents who have limited English proficiency (LEP). The investigators will focus on the use of trained community health workers (CHWs) to increase clinic capacity and quality of suicide risk screening and early intervention, with a focus on safety planning, parent psychoeducation and care coordination.

Specific aims are 1: To develop site-specific implementation protocols for the integration of CHWs into SIB screening and safety planning for Latinx youth and the youths families; 2: To pilot the implementation of the program in a six-month open trial in four pediatric primary care practices representing a range of usual practice settings; and 3: To engage a stakeholder network to explore barriers and facilitators, including costs and billing strategies, to implementation of this approach across a broad range of pediatric primary care settings.

Parents/guardians of youth who have been referred to and agree to participate in the intervention by the child's primary care provider will participate in a 2-month program consisting of 6-8 phone sessions with a community health worker focusing on safety planning, information/education, program solving and self-care. Research participants will be asked to complete a survey via phone at the beginning of the program and another at the end of the program. The participants may also be asked to participate in an additional interview about the study.

Being tested
PALOMA
Medical subject headings
Suicidal Ideation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PALOMABehavioural

    Partnering with Parents of Adolescent Latinos on Mental Health Assistance

Study groups in NCT06229223
Study groupRoleWhat they receive
PALOMAExperimentalParents/guardians of youth who have been referred to and agree to participate in the intervention by the child's primary care provider will participate in a 2-month program consisting of 5-7 phone sessions with a community health worker focusing on safety planning, information/education, program solving and self-care. Research participants will be asked to complete a survey via phone at the beginning of the program and another at the end of the program. The participants may also be asked to participate in an additional interview about the participants experience during the study.
Receives: Behavioral: PALOMA

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percent of Participants Screened

    Percent of patients 10-18 years old screened for depression and suicidal ideation and behavior at clinic level

    Measured: Monthly for 9 months

  2. Feasibility as assessed by percent of sessions completed

    Percent of eligible patients receiving a CHW session

    Measured: Monthly for 9 months

  3. Quality as assessed by percent of CHW visits

    Percent of CHW visits that include delivery of one or more intervention components

    Measured: Monthly for 9 months

  4. Engagement as assessed by number of follow-up visits

    number of follow-up mental health visits with PCP or specialty provider among youth identified as having suicidal ideation or behavior.

    Measured: Monthly for 9 months

Secondary outcomes (6)
  1. Family Functioning as assessed by the SCORE-15 Index of Family Functioning and Change (SCORE-15)

    SCORE-15 Index of Family Functioning and Change: Score range 5-15, higher total means worse functioning.

    Measured: Baseline and 3 months

  2. Parent Self Efficacy as assessed by Brief Parenting Self Efficacy Scale (BPSES) Questionnaire

    Brief Parenting Self Efficacy Scale (BPSES) Questionnaire: Total score ranges from 5 to 25, higher scores indicate higher levels of parental self-efficacy.

    Measured: Baseline and 3 months

  3. Depression as assessed by the Patient Health Questionnaire - Adolescent (PHQ-A)

    Patient Health Questionnaire - Adolescent (PHQ-A): Each item on the PHQ-A is scored as follows: Not at all = 0 Several Days = 1 More than half the days = 2 Nearly every day = 3. A weighted score of 5 or more means a positive screen for depressive symptoms. A weighted score of 0-4 means a negative screen for depressive symptoms.

    Measured: Baseline and 3 months

  4. Suicidal Ideation and Behavior as assessed by the Ask Suicide-Screening Questionnaire (ASQ)

    Ask Suicide-Screening Questionnaire (ASQ): 4 Yes or No Questions. "Yes" to questions 1 through 4, or refuses to answer is considered a positive screen. "Yes" to question 5 = acute positive screen (imminent risk identified); "No" to question 5 = non-acute positive screen.

    Measured: Baseline and 3 months

  5. Parental Self-Efficacy to Support Teens During a Suicidal Crisis survey

    9 items. Answer choices ranged from 0 (not at all confident) to 10 (completely confident), with an anchor of 5 (somewhat confident); score range 0-90; higher score higher confidence.

    Measured: Baseline and 3 months

  6. Parent expectations of adolescents' risk survey

    3 items. Answer choices ranged from 0 (not at all confident) to 10 (completely confident), with an anchor of 5 (somewhat confident). Score range 0-30; higher score higher confidence.

    Measured: Baseline and 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jan 2024
  2. Study start26 Mar 2024
  3. Primary completion6 Jan 2026
  4. Study completion6 Jan 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
76 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06229223
Sponsor's protocol ID
IRB00378575
Other IDs
R34MH129771
Status last verified
Apr 2026
First submitted
19 Jan 2024
Last updated
13 Apr 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Data will be made available while safeguarding the privacy of participants, \& protecting confidential \& proprietary data. Investigators will have access to results free from personal identifiers \& PHI. Investigators will fill out a request form that specifies the purpose of the request, the data requested \& the qualifications of the requestor. Final research data will include recorded factual material necessary to document \& support research findings, including final data sets (w/ identifiers redacted), data collection protocols data, \& database documentation. Users must agree to the conditions of use governing access to the publicly released data, including restrictions against attempting to identify study participants, destruction of the data after analyses are completed, reporting responsibilities, restrictions on redistribution of the data to third parties, restrictions on use for commercial purposes, \& proper acknowledgement of the data resource.

Questions about this trial

What is this clinical trial studying?

A study testing PALOMA in people with Suicidal Ideation, run by Johns Hopkins University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percent of Participants Screened (time frame: Monthly for 9 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in